The Food and Drug Administration (FDA) has approved Qternmet XR (AstraZeneca) as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D).
{iframe}https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/fda-approves-new-combination-therapy-for-type-2-diabetes/{/iframe}